Notify me when C/M Capital Partners, Lp files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| BDRX | Biodexa Pharmaceuticals Plc | Ordinary Shares, nominal value 0.00005 GBP per share | 6.8% | $2.61B | $2.61B | 1.75B | Jonathan Juchno | 20 May 2025 | |
| FORD | Forward Industries, Inc. | Common Stock, par value $0.01 per share | 1.6% | $36.6M | $33.6M | 1.38M | +1101% | C/M CAPITAL PARTNERS, LP | 30 Sep 2025 |
| BDRX | Biodexa Pharmaceuticals Plc | Ordinary Shares, nominal value 0.000001 GBP per share | 0% | $0 | 0 | Cavalry Fund I LP | 30 Jun 2025 | ||
| IPST | Heritage Distilling Holding Company, Inc. | Common Stock, par value $0.0001 per share | 0% | $0 | -$1.82M | 0 | -100% | C/M Capital Master Fund, LP | 30 Sep 2025 |
| AUUD | AUDDIA INC. | Common Stock, par value $0.001 per share | 0% | $0 | -$74.8K | 0 | -100% | Cavalry Fund I LP | 30 Sep 2025 |
| SLRX | Salarius Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 0% | $0 | 0 | C/M Capital Master Fund, LP | 07 Oct 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|